IITDLogo
Conflict of Interest and its Significance in Science and Medicine

International Conference on

Conflict of Interest and its Significance in Science and Medicine

Warsaw, 5-6 April 2002

DAY 1

PLENARY SESSION I

9:15 - 9:40Conflict of Interest in Science and Medicine - the Physician's perspective (D. Human, Secretary General & CEO, The World Medical Association)
9:40 - 11:05Presentations from Council of Europe (P. Zilgalvis), European Commission (M. Salvi), European Science Foundation (J. Degett), European Forum for Good Clinical Practice (F. Crawley)
11:05 - 11:20(title to be announced) (E. Doppelfeld, CDBI, Council of Europe; Editor, Deutsches Aerzteblatt)
11:20 – 11:45Conflict of Interest in Medicine (C.D. de Angelis, Editor-in-Chief, Journal of American Medical Association)
11:45 - 12:15Coffee Break
12:15 - 12:40The continuing need for disinterested research (J.M. Ziman, UK)
12:40 - 13:05Conflict of Interest: the Importance of Potential (I. Evans, Medical Research Council, London, UK)
13:05 - 13:35Discussion
13:35 - 14:35Lunch


PLENARY SESSION II

14:35 - 15:00Academic/Industrial Relationships : Opportunities and Pitfalls (J.B.Martin, Dean of the Medical Faculty, Harvard Medical School, USA)
15:00 - 15:25Investigator, Stock Holder, and Decision Makers: Who Owns the Data and Who Makes the Decisions? (J.M. Drazen, Editor-in-Chief, the New England Journal of Medicine)
15:25 - 15:50Managing Financial Conflicts of Interest in Research: a Public/Private Partnership (J. Cohen, President, The Association of American Medical Colleges)
15:50 - 16:15Individual and Institutional Conflict of Interest: Policy Review by Research Universities in the United States (N. Hasselmo, President, the Association of American Universities)
16:15 - 16:30Coffee Break
16:30 - 16:55Conflicts of Interests in Drug Development – The Practices of Merck & Co., Inc (L. Hirsch, Vice-President, Merck Research Laboratories)
16:55 - 17:20Funding and Objectivity in Research (J. Brown, University of Toronto, Canada)
17:20 - 17:45The impact of conflicts of interest on trust in science (P.J. Friedman, University of California, San Diego)
17:45 – 18:15Discussion


DAY 2

PLENARY SESSION III

8:30 – 8:55Beyond Conflict of Interest: the Responsible Conduct of Research (L. Rhoades, Office of Research Integrity, US Department of Health and Human Services)
8:55 - 9:20Financial and Non-Financial Conflicts of Interest: How to Identify and Manage Them (M.F. Marshall, The National Human Research Protection Advisory Committee, USA)
9:20 - 9:45Conflict or Harmony? Clinical Research and Medical Press in Russia (B. Lichterman, Russia)
9:45 - 10:10Conflict of Interest in Germany: a Legal Perspective (Ch. Lux, University of Cologne, Germany)
10:10 - 10:35Legal remedies for the conflict of interests in biomedical science (J.Sandor, Central-Eastern University, Budapest, Hungary)
10:35 - 11:00Conflict of Interest as Seen From a Researcher's Perspective (G.Remuzzi, Director, Mario Negri Institute, Italy)
11:00 - 11:30Discussion
11:30 - 11:50Coffee Break
11:50 - 13:00 SHORT COMMUNICATIONS

Ch. Byk (France), A. Jafarey (Pakistan), B. Jansen (Germany), O. Konttinen (Finland), O. Kubar (Russia), B.Vrhovac (Croatia), K. Zapotoczky (Austria), and others.
13:00 - 13:40Lunch
13:40 - 14:20Meeting with students



SESSION IV: Conflict of Interest: a View From Eastern Europe

14:20 - 14:45The Need to Deal With Conflict of Interest in Eastern Europe (A. Gorski, Bioethics Commissions, Poland)
14:45 - 16:30Short Presentations by representatives of Armenia, Bulgaria, Croatia, Estonia, Hungary, Latvia, Lithuania, Romania, Russia, Slovakia, Ukraine
16:30 - 17:00Discussion


SUMMARY AND CONCLUSIONS

W. Baldwin (Deputy Director, National Institutes of Health, USA)


Further information and registration: www.abacus.edu.pl,  tel. (+48 22) 836 04 16